{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T22:35:08Z","timestamp":1791412508789,"version":"4.3.3"},"reference-count":75,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T00:00:00Z","timestamp":1767916800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100011725","name":"Servier","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.jtha.2025.12.018","type":"journal-article","created":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T00:23:56Z","timestamp":1768004636000},"page":"1609-1619","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Prevention and treatment of thrombosis in patients with decompensated cirrhosis"],"prefix":"10.1016","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5595-8246","authenticated-orcid":false,"given":"Conor","family":"Bell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amber","family":"Afzal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Carlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lara N.","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtha.2025.12.018_bib1","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1111\/apt.17368","article-title":"Review article: diagnosis, pathophysiology and management of atrial fibrillation in cirrhosis and portal hypertension","volume":"57","author":"Vandenberk","year":"2023","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jtha.2025.12.018_bib2","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.118.008703","article-title":"Liver disease as a predictor of new-onset atrial fibrillation","volume":"7","author":"Huang","year":"2018","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jtha.2025.12.018_bib3","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.jhep.2021.04.029","article-title":"Current knowledge and management of portal vein thrombosis in cirrhosis","volume":"75","author":"Senzolo","year":"2021","journal-title":"J Hepatol"},{"key":"10.1016\/j.jtha.2025.12.018_bib4","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1160\/TH16-06-0450","article-title":"The risk of venous thromboembolism in patients with cirrhosis","volume":"26","author":"Ambrosino","year":"2017","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.12.018_bib5","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1038\/ajg.2017.457","article-title":"Platelet count does not predict bleeding in cirrhotic patients: results from the PRO-LIVER study","volume":"113","author":"Basili","year":"2018","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jtha.2025.12.018_bib6","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1055\/s-0040-1714205","article-title":"Incidence of bleeding and thrombosis in patients with liver disease","volume":"46","author":"Roberts","year":"2020","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.jtha.2025.12.018_bib7","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1002\/hep.27783","article-title":"Impact of anticoagulation on upper-gastrointestinal bleeding in cirrhosis. A retrospective multicenter study","volume":"62","author":"Cerini","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.jtha.2025.12.018_bib8","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/j.amjmed.2019.01.006","article-title":"Anticoagulation therapy in patients with liver cirrhosis is associated with an increased risk of variceal hemorrhage","volume":"132","author":"Sasso","year":"2019","journal-title":"Am J Med"},{"key":"10.1016\/j.jtha.2025.12.018_bib9","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1053\/j.gastro.2012.07.018","article-title":"Enoxaparin prevents portal vein thrombosis and liver decompensation in patients with advanced cirrhosis","volume":"143","author":"Villa","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jtha.2025.12.018_bib10","doi-asserted-by":"crossref","first-page":"S52","DOI":"10.1016\/S0168-8278(23)00442-7","article-title":"Rivaroxaban improves survival and decompensation in cirrhotic patients with moderate liver dysfunction. Double-blind, placebo-controlled trial","volume":"78","author":"Sanchez","year":"2023","journal-title":"J Hepatol"},{"key":"10.1016\/j.jtha.2025.12.018_bib11","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1111\/jth.15239","article-title":"The concept of rebalanced hemostasis in patients with liver disease: communication from the ISTH SSC working group on hemostatic management of patients with liver disease","volume":"19","author":"Lisman","year":"2021","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.12.018_bib12","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/hep.23653","article-title":"Detection of the imbalance of procoagulant versus anticoagulant factors in cirrhosis by a simple laboratory method","volume":"52","author":"Tripodi","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.jtha.2025.12.018_bib13","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.dld.2018.12.001","article-title":"Efficacy and safety of anticoagulation for atrial fibrillation in patients with cirrhosis: a systematic review and meta-analysis","volume":"51","author":"Chokesuwattanaskul","year":"2019","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.jtha.2025.12.018_bib14","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1111\/apt.16078","article-title":"Systematic review with meta-analysis: abnormalities in the international normalised ratio do not correlate with periprocedural bleeding events among patients with cirrhosis","volume":"52","author":"Kovalic","year":"2020","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jtha.2025.12.018_bib15","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/S0140-6736(13)62343-0","article-title":"Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials","volume":"383","author":"Ruff","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.jtha.2025.12.018_bib16","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1182\/blood-2014-04-571232","article-title":"Direct oral anticoagulants compared with vitamin K antagonists for acute venous thromboembolism: evidence from phase 3 trials","volume":"124","author":"van Es","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2025.12.018_bib17","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.1016\/j.jtha.2024.05.023","article-title":"Anticoagulation for stroke prevention in atrial fibrillation and treatment of venous thromboembolism and portal vein thrombosis in cirrhosis: guidance from the SSC of the ISTH","volume":"22","author":"Carlin","year":"2024","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.12.018_bib18","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/j.jhep.2021.09.003","article-title":"EASL Clinical Practice Guidelines on prevention and management of bleeding and thrombosis in patients with cirrhosis","volume":"76","year":"2022","journal-title":"J Hepatol"},{"key":"10.1016\/j.jtha.2025.12.018_bib19","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.jhep.2021.12.022","article-title":"Baveno VII\u2014renewing consensus in portal hypertension","volume":"76","author":"de Franchis","year":"2022","journal-title":"J Hepatol"},{"key":"10.1016\/j.jtha.2025.12.018_bib20","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/S2468-1253(24)00155-9","article-title":"Portal vein thrombosis: diagnosis, management, and endpoints for future clinical studies","volume":"9","author":"Elkrief","year":"2024","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.jtha.2025.12.018_bib21","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1093\/ehjcvp\/pvab032","article-title":"Anticoagulation in atrial fibrillation and liver disease: a pooled-analysis of >20 000 patients","volume":"8","author":"Chen","year":"2022","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"key":"10.1016\/j.jtha.2025.12.018_bib22","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/hep.31264","article-title":"Mortality and hepatic decompensation in patients with cirrhosis and atrial fibrillation treated with anticoagulation","volume":"73","author":"Serper","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.jtha.2025.12.018_bib23","doi-asserted-by":"crossref","DOI":"10.1002\/jgh3.13074","article-title":"Safety of DOACs in patients with Child-Pugh Class C cirrhosis and atrial fibrillation","volume":"8","author":"Ayoub","year":"2024","journal-title":"JGH Open"},{"key":"10.1016\/j.jtha.2025.12.018_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.rpth.2023.100052","article-title":"Clinically relevant increases in the international normalized ratio and model of end-stage liver disease score by therapeutic doses of direct oral anticoagulants in patients with cirrhosis","volume":"7","author":"Lisman","year":"2023","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.12.018_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.thromres.2025.109529","article-title":"Association of anticoagulant therapy with bleeding in patients with chronic liver disease: a case-cross over study using the National Veterans Health Administration database","volume":"256","author":"Mahmoud","year":"2025","journal-title":"Thromb Res"},{"key":"10.1016\/j.jtha.2025.12.018_bib26","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1136\/hrt.2007.135657","article-title":"Warfarin for the prevention of systemic embolism in patients with non-valvular atrial fibrillation: a meta-analysis","volume":"94","author":"Andersen","year":"2008","journal-title":"Heart"},{"key":"10.1016\/j.jtha.2025.12.018_bib27","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s40256-019-00369-x","article-title":"Non-vitamin K antagonist oral anticoagulants versus warfarin in patients with atrial fibrillation and liver disease: a meta-analysis and systematic review","volume":"20","author":"Fu","year":"2020","journal-title":"Am J Cardiovasc Drugs"},{"key":"10.1016\/j.jtha.2025.12.018_bib28","doi-asserted-by":"crossref","DOI":"10.1111\/eci.13397","article-title":"CAR. Direct oral anticoagulants and advanced liver disease: a systematic review and meta-analysis","volume":"51","author":"Menichelli","year":"2021","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.jtha.2025.12.018_bib29","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1007\/s10557-020-07065-y","article-title":"Efficacy and safety of direct oral anticoagulants in patients with atrial fibrillation and liver disease: a meta-analysis and systematic review","volume":"35","author":"Huang","year":"2021","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1016\/j.jtha.2025.12.018_bib30","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1161\/CIRCOUTCOMES.113.000817","article-title":"Stratifying the risks of oral anticoagulation in patients with liver disease","volume":"7","author":"Efird","year":"2014","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.jtha.2025.12.018_bib31","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1161\/CIR.0000000000001193","article-title":"2023 ACC\/AHA\/ACCP\/HRS guideline for the diagnosis and management of atrial fibrillation: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"149","author":"Joglar","year":"2024","journal-title":"Circulation"},{"key":"10.1016\/j.jtha.2025.12.018_bib32","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1093\/europace\/euab065","article-title":"2021 European Heart Rhythm Association practical guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation","volume":"23","author":"Steffel","year":"2021","journal-title":"EP Europace"},{"key":"10.1016\/j.jtha.2025.12.018_bib33","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.7326\/M23-3067","article-title":"Comparative effectiveness and safety of apixaban, rivaroxaban, and warfarin in patients with cirrhosis and atrial fibrillation","volume":"177","author":"Simon","year":"2024","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jtha.2025.12.018_bib34","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1161\/CIRCULATIONAHA.122.060687","article-title":"Comparative effectiveness and safety of direct oral anticoagulants and warfarin in patients with atrial fibrillation and chronic liver disease: a nationwide cohort study","volume":"147","author":"Lawal","year":"2023","journal-title":"Circulation"},{"key":"10.1016\/j.jtha.2025.12.018_bib35","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1016\/j.jacc.2015.09.024","article-title":"Gastrointestinal bleeding in patients with atrial fibrillation treated with rivaroxaban or warfarin: ROCKET AF trial","volume":"66","author":"Sherwood","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jtha.2025.12.018_bib36","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.dld.2015.01.159","article-title":"Impact of new oral anticoagulants on gastrointestinal bleeding in atrial fibrillation: a meta-analysis of interventional trials","volume":"47","author":"Loffredo","year":"2015","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.jtha.2025.12.018_bib37","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.7326\/M21-1474","article-title":"Rivaroxaban is associated with higher rates of gastrointestinal bleeding than other direct oral anticoagulants : a nationwide propensity score-weighted study","volume":"174","author":"Ingason","year":"2021","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jtha.2025.12.018_bib38","doi-asserted-by":"crossref","first-page":"445","DOI":"10.3390\/biomedicines9050445","article-title":"Laboratory monitoring of direct oral anticoagulants (DOACs)","volume":"9","author":"Dunois","year":"2021","journal-title":"Biomedicines"},{"key":"10.1016\/j.jtha.2025.12.018_bib39","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/0003-4975(95)00887-X","article-title":"Appendage obliteration to reduce stroke in cardiac surgical patients with atrial fibrillation","volume":"61","author":"Blackshear","year":"1996","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.jtha.2025.12.018_bib40","doi-asserted-by":"crossref","first-page":"3314","DOI":"10.1093\/eurheartj\/ehae176","article-title":"2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)","volume":"45","author":"Van Gelder","year":"2024","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jtha.2025.12.018_bib41","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/S0140-6736(09)61343-X","article-title":"Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial","volume":"374","author":"Holmes","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.jtha.2025.12.018_bib42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jacc.2014.04.029","article-title":"Prospective randomized evaluation of the Watchman Left Atrial Appendage Closure device in patients with atrial fibrillation versus long-term warfarin therapy: the PREVAIL trial","volume":"64","author":"Holmes","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jtha.2025.12.018_bib43","doi-asserted-by":"crossref","first-page":"3122","DOI":"10.1016\/j.jacc.2020.04.067","article-title":"Left atrial appendage closure versus direct oral anticoagulants in high-risk patients with atrial fibrillation","volume":"75","author":"Osmancik","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jtha.2025.12.018_bib44","doi-asserted-by":"crossref","first-page":"2964","DOI":"10.1016\/j.jacc.2017.10.021","article-title":"5-year outcomes after left atrial appendage closure: from the PREVAIL and PROTECT AF trials","volume":"70","author":"Reddy","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jtha.2025.12.018_bib45","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.013525","article-title":"Net clinical benefit of left atrial appendage closure versus warfarin in patients with atrial fibrillation: a pooled analysis of the randomized PROTECT-AF and PREVAIL studies","volume":"8","author":"Brouwer","year":"2019","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jtha.2025.12.018_bib46","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1056\/NEJMoa2101897","article-title":"Left atrial appendage occlusion during cardiac surgery to prevent stroke","volume":"384","author":"Whitlock","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtha.2025.12.018_bib47","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.jacep.2018.03.009","article-title":"Thoracoscopic left atrial appendage clipping: a multicenter cohort analysis","volume":"4","author":"van Laar","year":"2018","journal-title":"JACC Clin Electrophysiol"},{"key":"10.1016\/j.jtha.2025.12.018_bib48","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1016\/j.hlc.2024.02.010","article-title":"Thoracoscopic left atrial appendage occlusion with the AtriClip PRO2: an experience of 144 patients","volume":"33","author":"Wang","year":"2024","journal-title":"Heart Lung Circ"},{"key":"10.1016\/j.jtha.2025.12.018_bib49","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.amjcard.2023.06.026","article-title":"Long-term imaging and clinical outcomes of surgical left atrial appendage occlusion with AtriClip","volume":"201","author":"Ahmed","year":"2023","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jtha.2025.12.018_bib50","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1093\/europace\/euad004","article-title":"Left atrial appendage closure device outcomes among cirrhosis patients with atrial fibrillation: a United States National Cohort Study","volume":"25","author":"Mir","year":"2023","journal-title":"Europace"},{"key":"10.1016\/j.jtha.2025.12.018_bib51","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1016\/j.hrthm.2022.04.009","article-title":"Liver cirrhosis is independently associated with increased in-hospital mortality in patients undergoing left atrial appendage occlusion device implantation","volume":"19","author":"Thotamgari","year":"2022","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jtha.2025.12.018_bib52","first-page":"41","article-title":"Ablation of atrial fibrillation and risk of stroke: a meta-analysis","volume":"3","author":"Providencia","year":"2026","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jtha.2025.12.018_bib53","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/jce.16472","article-title":"Safety of catheter ablation for atrial fibrillation in patients with liver cirrhosis","volume":"36","author":"Barrera","year":"2025","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.jtha.2025.12.018_bib54","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1056\/NEJMoa1007432","article-title":"Apixaban in patients with atrial fibrillation","volume":"364","author":"Connolly","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtha.2025.12.018_bib55","doi-asserted-by":"crossref","first-page":"857","DOI":"10.7326\/0003-4819-146-12-200706190-00007","article-title":"Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation","volume":"146","author":"Hart","year":"2007","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jtha.2025.12.018_bib56","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1016\/j.jcin.2021.07.031","article-title":"Half-dose direct oral anticoagulation versus standard antithrombotic therapy after left atrial appendage occlusion","volume":"14","author":"Della Rocca","year":"2021","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.jtha.2025.12.018_bib57","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1007\/s11739-016-1416-8","article-title":"Portal vein thrombosis relevance on liver cirrhosis: Italian Venous Thrombotic Events Registry","volume":"11","author":"Violi","year":"2016","journal-title":"Intern Emerg Med"},{"key":"10.1016\/j.jtha.2025.12.018_bib58","first-page":"265","article-title":"Spontaneous resolution of portal vein thrombosis in cirrhosis: where do we stand, and where will we go? Saudi","volume":"20","author":"Qi","year":"2014","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.jtha.2025.12.018_bib59","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1002\/hep.32169","article-title":"Nonmalignant portal vein thrombi in patients with cirrhosis consist of intimal fibrosis with or without a fibrin-rich thrombus","volume":"75","author":"Driever","year":"2022","journal-title":"Hepatology"},{"key":"10.1016\/j.jtha.2025.12.018_bib60","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1053\/j.gastro.2024.10.038","article-title":"AGA clinical practice update on management of portal vein thrombosis in patients with cirrhosis: expert review","volume":"168","author":"Davis","year":"2025","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jtha.2025.12.018_bib61","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.jhep.2023.01.007","article-title":"Alternative forms of portal vein revascularization in liver transplant recipients with complex portal vein thrombosis","volume":"78","author":"Fundora","year":"2023","journal-title":"J Hepatol"},{"key":"10.1016\/j.jtha.2025.12.018_bib62","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1111\/tri.13353","article-title":"Mortality in liver transplant recipients with portal vein thrombosis\u2014an updated meta-analysis","volume":"31","author":"Zanetto","year":"2018","journal-title":"Transpl Int"},{"key":"10.1016\/j.jtha.2025.12.018_bib63","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jhep.2023.02.023","article-title":"Anticoagulation improves survival in patients with cirrhosis and portal vein thrombosis: the IMPORTAL competing-risk meta-analysis","volume":"79","author":"Guerrero","year":"2023","journal-title":"J Hepatol"},{"key":"10.1016\/j.jtha.2025.12.018_bib64","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.jceh.2022.12.016","article-title":"Anticoagulation for the treatment of portal vein thrombosis in cirrhosis: a systematic review and meta-analysis of comparative studies","volume":"13","author":"Yao","year":"2023","journal-title":"J Clin Exp Hepatol"},{"key":"10.1016\/j.jtha.2025.12.018_bib65","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1053\/j.gastro.2017.04.042","article-title":"Effects of anticoagulants in patients with cirrhosis and portal vein thrombosis: a systematic review and meta-analysis","volume":"153","author":"Loffredo","year":"2017","journal-title":"Gastroenterology"},{"issue":"1S Suppl 1","key":"10.1016\/j.jtha.2025.12.018_bib66","doi-asserted-by":"crossref","first-page":"e423","DOI":"10.1097\/MEG.0000000000002123","article-title":"Natural history and predictors associated with the evolution of portal venous system thrombosis in liver cirrhosis","volume":"33","author":"Xu","year":"2021","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.jtha.2025.12.018_bib67","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.dld.2021.07.039","article-title":"Efficacy and safety of direct oral anticoagulants versus vitamin K antagonist for portal vein thrombosis in cirrhosis: a systematic review and meta-analysis","volume":"54","author":"Koh","year":"2022","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.jtha.2025.12.018_bib68","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1002\/rth2.12359","article-title":"Direct oral anticoagulants compared to low-molecular-weight heparin for the treatment of cancer-associated thrombosis: updated systematic review and meta-analysis of randomized controlled trials","volume":"4","author":"Moik","year":"2020","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.12.018_bib69","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1111\/jth.15789","article-title":"Anticoagulation in thrombocytopenic patients\u2014time to rethink?","volume":"20","author":"Thachil","year":"2022","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.12.018_bib70","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1056\/NEJM196205032661802","article-title":"The quantitative relation between platelet count and hemorrhage in patients with acute leukemia","volume":"266","author":"Gaydos","year":"1962","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtha.2025.12.018_bib71","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1111\/jth.14015","article-title":"Management of cancer-associated thrombosis in patients with thrombocytopenia: guidance from the SSC of the ISTH","volume":"16","author":"Samuelson Bannow","year":"2018","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.12.018_bib72","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1002\/hep4.1641","article-title":"Reduced clot stability by thromboelastography as a potential indicator of procedure-related bleeding in decompensated cirrhosis","volume":"5","author":"Zanetto","year":"2021","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.jtha.2025.12.018_bib73","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1053\/j.gastro.2023.05.046","article-title":"Procedural-Related Bleeding in Hospitalized Patients With Liver Disease (PROC-BLeeD): an international, prospective, multicenter observational study","volume":"165","author":"Intagliata","year":"2023","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jtha.2025.12.018_bib74","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/hep.21231","article-title":"Elevated levels of von Willebrand factor in cirrhosis support platelet adhesion despite reduced functional capacity","volume":"44","author":"Lisman","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.jtha.2025.12.018_bib75","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/jth.15562","article-title":"Periprocedural management of abnormal coagulation parameters and thrombocytopenia in patients with cirrhosis: guidance from the SSC of the ISTH","volume":"20","author":"Roberts","year":"2022","journal-title":"J Thromb Haemost"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783626000073?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783626000073?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T19:59:01Z","timestamp":1783972741000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783626000073"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":75,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S1538783626000073"],"URL":"https:\/\/doi.org\/10.1016\/j.jtha.2025.12.018","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prevention and treatment of thrombosis in patients with decompensated cirrhosis","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtha.2025.12.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of International Society on Thrombosis and Haemostasis.","name":"copyright","label":"Copyright"}]}}